fda compounding semaglutide enforcement 2025 news Warns on Certain Forms of Compounded fda compounding semaglutide enforcement november

It is important to use a trusted prescriber such as a GP, bariatric physician or bariatric surgeon and to use a reputable pharmacy when using semaglutide or any weight loss drug, says Dr Winnett

Compounded Medications Are Not FDA-Approved Because of this, compounded solutions may carry different risks than FDA-approved versions

Researchers continue to monitor this phenomenon in ongoing trials to ensure long-term cardiovascular safety, particularly for individuals with pre-existing heart conditions

labels approve the same uses

In diabetes trials, injectable semaglutide 1 mg produced mean weight loss of 46 kg (approximately 913 lbs), while oral semaglutide 14 mg resulted in weight loss of approximately 34 kg (79 lbs)

Roughly three out of four patients experience some form of nausea during the first four weeks, but most patients say the discomfort is tolerable